Clinical trial
Study of Cetuximab With Radiation Followed by Consolidation Chemotherapy for…
NCT00492206 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00492206 |
|---|---|
| Title | Study of Cetuximab With Radiation Followed by Consolidation Chemotherapy for NSCLC |
| Official title | A Phase II Study of Cetuximab in Combination With External Beam Radiation Followed By Consolidation Chemotherapy for Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC) |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non Small Cell Lung Cancer (NSCLC) |
| Intervention type | Drug |
| Interventions | Cetuximab |
| Enrollment | 40 |
| Start date | Jun 1, 2006 |
| Primary completion | Feb 1, 2012 |
| Completion | Feb 1, 2012 |
| First posted | Jun 27, 2007 |
| Last update posted | Feb 1, 2017 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: